• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Allergan

Allergan

Allergan PLC AGN

Last Price$248.95Day Change (%)0.44%
Open Price$247.37Day Change ($)1.10
Day Range246.82–250.7552-Week Range195.50–340.34

As of Tue 7/26/2016 7:55:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Fitch Rates Teva Pharmaceutical's New EUR and CHF Bonds 'BBB'

    Fitch Rates Teva Pharmaceutical's New EUR and CHF Bonds 'BBB'

  2. Mayne Pharma Buys US Drugs from Teva, Allergan for $652 Million

    Mayne Pharma Buys US Drugs from Teva, Allergan for $652 Million

  3. Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020 - Paradigm Shift to Non-Estrogenic Therapies - Research and Markets

    Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020 - Paradigm Shift to Non-Estrogenic Therapies - Research and Markets

  4. Teva Sells $15 Billion of Bonds

    Teva Sells $15 Billion of Bonds

  5. Teva Finalizes Bond Sale

    Teva Finalizes Bond Sale

  6. Jury Acquits Former Johnson & Johnson Unit Executives of Felony Fraud

    Jury Acquits Former Johnson & Johnson Unit Executives of Felony Fraud

  7. Jury Acquits Former Johnson & Johnson Unit Executives of Felony Fraud

    Jury Acquits Former Johnson & Johnson Unit Executives of Felony Fraud

  8. Teva Raises Guidance

    Teva Raises Guidance

  9. ADRs End Mostly Lower; Nokia Rises

    ADRs End Mostly Lower; Nokia Rises

  10. Teva and the Huntington Study Group Announce Publication of Pivotal Phase III Data on Deutetrabenazine (SD-809) in Huntington Disease from First-HD Trial in JAMA

    Teva and the Huntington Study Group Announce Publication of Pivotal Phase III Data on Deutetrabenazine (SD-809) in Huntington Disease from First-HD Trial in JAMA

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.